CRYO-CELL INTERNATIONAL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for the quarter ending 2021-11-30 was -$924.12K.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for the quarter ending 2021-08-31 was -$142.17K.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for the quarter ending 2021-05-31 was $4.46M.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for the quarter ending 2021-02-28 was $191.62K, a 367.37% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for fiscal 2021 was $3.59M, a 8644.32% increase from fiscal 2020.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for fiscal 2020 was $41.00K, a 619.30% increase from fiscal 2019.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for fiscal 2019 was $5.70K, a 99.84% decline from fiscal 2018.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, new issues for fiscal 2018 was $3.67M, a 5574.11% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-11-30 | -$924.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.59M 10-K · filed 2023-02-28 |
| 2021-08-31 | -$142.17K 10-Q · filed 2021-10-15 | $4.51M derived: sum of 4 quarters · filed 2021-10-15 |
| 2021-05-31 | $4.46M 10-Q · filed 2021-07-15 | $4.65M derived: sum of 4 quarters · filed 2021-10-15 |
| 2021-02-28 | $191.62K 10-Q · filed 2021-04-14 | $191.62K derived: sum of 4 quarters · filed 2021-10-15 |
| 2020-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $41.00K 10-K · filed 2021-03-01 |
| 2020-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-15 | $41.00K derived: sum of 4 quarters · filed 2021-10-15 |
| 2020-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-15 | $41.00K derived: sum of 4 quarters · filed 2021-07-15 |
| 2020-02-29 | $41.00K 10-Q · filed 2021-04-14 | $41.00K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.70K 10-K · filed 2021-03-01 |
| 2019-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-15 | $5.70K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-10 | $3.67M derived: sum of 4 quarters · filed 2020-07-10 |
| 2019-02-28 | $5.70K 10-Q · filed 2020-04-14 | $3.67M derived: sum of 4 quarters · filed 2020-04-14 |
| 2018-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.67M 10-K · filed 2020-02-28 |
| 2018-08-31 | $3.67M 10-Q · filed 2019-10-15 | |
| 2018-05-31 | $2.67K 10-Q · filed 2019-07-15 | |
| 2018-02-28 | $2.25K 10-Q · filed 2019-04-15 | |
| 2017-11-30 | $64.70K 10-K · filed 2019-02-28 | |
| 2016-11-30 | $40.34K 10-K · filed 2018-02-28 | |
| 2015-11-30 | $69.85K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |